Lawmakers caught between the threat of rising drug costs and fears that a proposed nationwide Centers for Medicare & Medicaid Services (CMS) Part B drug reimbursement pilot would be bad for patients held to their individual calls for CMS to either scrap or modify the program during a Tuesday hearing of the House Energy and Commerce Health Subcommittee, suggesting little potential for the experiment to find much support there.